Considerations in the management of parkinsonism.
D000547:Amantadine / Q000627:therapeutic use; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*
D010276:Parasympatholytics; D007980:Levodopa; D000547:Amantadine; D002262:Carboxy-Lyases